Hydromer, Inc. HYDI

Company Overview

Hydromer, Inc. (OTC: HYDI) is a specialty materials and coatings company focused primarily on hydrophilic coating technologies used in medical devices and related healthcare applications. The company develops proprietary polymer-based coatings designed to reduce friction, improve lubricity, and enhance biocompatibility for products such as catheters, guidewires, and other minimally invasive medical instruments. Hydromer operates within the broader medical technology, biomaterials, and specialty chemical industries, with revenue historically tied to coating services, licensing arrangements, and product development agreements with medical device manufacturers.

Hydromer’s core positioning has historically centered on its expertise in hydrophilic polymer chemistry and surface modification technologies. The company traces its origins to the commercialization of water-absorbing polymer coatings intended to improve device performance and patient outcomes. Public disclosures indicate that Hydromer evolved from a research-oriented coatings developer into a niche supplier serving medical device OEMs and healthcare-related industrial customers. Data regarding the company’s current scale, market share, and recent operational expansion is limited in publicly available filings, and some operational details are inconclusive based on available public sources.